Immutep Valuation
| PRRUF Stock | USD 0.20 0.00 0.00% |
Immutep seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Immutep Limited from evaluating the firm fundamentals such as Return On Asset of -0.23, return on equity of -0.38, and Shares Outstanding of 879.09 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Immutep's price fluctuation is out of control at this time. Calculation of the real value of Immutep Limited is based on 3 months time horizon. Increasing Immutep's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Immutep pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Immutep Limited. Since Immutep is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immutep Pink Sheet. However, Immutep's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.17 | Hype 0.2 |
The real value of Immutep Pink Sheet, also known as its intrinsic value, is the underlying worth of Immutep Limited Company, which is reflected in its stock price. It is based on Immutep's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Immutep's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Immutep Limited helps investors to forecast how Immutep pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immutep more accurately as focusing exclusively on Immutep's fundamentals will not take into account other important factors: Immutep Total Value Analysis
Immutep Limited is at this time anticipated to have takeover price of 142.99 M with market capitalization of 171.77 M, debt of 2.11 M, and cash on hands of 80 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Immutep fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
142.99 M | 171.77 M | 2.11 M | 80 M |
Immutep Investor Information
About 24.0% of the company shares are owned by institutional investors. The book value of Immutep was at this time reported as 0.11. The company recorded a loss per share of 0.02. Immutep Limited had not issued any dividends in recent years. The entity had 1:10 split on the 5th of November 2019. Based on the analysis of Immutep's profitability, liquidity, and operating efficiency, Immutep Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Immutep Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Immutep has an asset utilization ratio of 0.17 percent. This implies that the Company is making $0.001668 for each dollar of assets. An increasing asset utilization means that Immutep Limited is more efficient with each dollar of assets it utilizes for everyday operations.Immutep Ownership Allocation
Immutep Limited has a total of 879.09 Million outstanding shares. Immutep retains 4.61 (percent) of its outstanding shares held by insiders and 24.04 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Immutep Profitability Analysis
The company reported the revenue of 247.66 K. Net Loss for the year was (32.21 M) with loss before overhead, payroll, taxes, and interest of (26.63 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Immutep's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Immutep and how it compares across the competition.
About Immutep Valuation
The pink sheet valuation mechanism determines Immutep's current worth on a weekly basis. Our valuation model uses a comparative analysis of Immutep. We calculate exposure to Immutep's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Immutep's related companies.Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Immutep's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Immutep's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Immutep's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Immutep's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Immutep's revenue streams: Identify Immutep's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Immutep's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Immutep's growth potential: Evaluate Immutep's management, business model, and growth potential.
- Determine Immutep's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Immutep's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Immutep Growth Indicators
Investing in growth stocks can be very risky. If the company such as Immutep does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 866.2 M | |
| Retained Earnings | -302.3 M |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |